Perrigo Co. Plc (PRGO)
14.64
+0.16
(+1.10%)
USD |
NYSE |
Aug 31, 16:00
14.64
0.00 (0.00%)
Pre-Market: 20:00
Perrigo Cash from Investing (Quarterly) : 349.40M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 349.40M |
| March 31, 2026 | -12.40M |
| December 31, 2025 | -24.50M |
| September 30, 2025 | -21.40M |
| June 30, 2025 | -3.80M |
| March 31, 2025 | -25.70M |
| December 31, 2024 | -37.10M |
| September 30, 2024 | 212.70M |
| June 30, 2024 | -73.30M |
| March 31, 2024 | -23.50M |
| December 31, 2023 | -22.80M |
| September 30, 2023 | -30.70M |
| June 30, 2023 | -4.40M |
| March 31, 2023 | -19.60M |
| December 31, 2022 | -26.00M |
| September 30, 2022 | -20.90M |
| June 30, 2022 | -1.974B |
| March 31, 2022 | 62.70M |
| December 31, 2021 | -41.90M |
| September 30, 2021 | 1.454B |
| June 30, 2021 | -21.80M |
| March 31, 2021 | -114.00M |
| December 31, 2020 | -127.50M |
| September 30, 2020 | -38.60M |
| June 30, 2020 | 53.10M |
| Date | Value |
|---|---|
| March 31, 2020 | -74.80M |
| December 31, 2019 | -106.30M |
| September 30, 2019 | -651.80M |
| June 30, 2019 | -68.10M |
| March 31, 2019 | 230.10M |
| December 31, 2018 | -46.10M |
| September 30, 2018 | -51.50M |
| June 30, 2018 | -27.10M |
| March 31, 2018 | -2.10M |
| December 31, 2017 | 66.00M |
| September 30, 2017 | -9.90M |
| June 30, 2017 | -5.80M |
| March 31, 2017 | 2.288B |
| December 31, 2016 | 94.50M |
| September 30, 2016 | 38.40M |
| June 30, 2016 | 60.80M |
| March 31, 2016 | -368.70M |
| December 31, 2015 | 1.814B |
| September 30, 2015 | -367.30M |
| June 30, 2015 | -2.075B |
| March 31, 2015 | -246.20M |
| June 30, 2014 | -59.10M |
| March 31, 2014 | -46.20M |
| December 31, 2013 | -1.564B |
| September 30, 2013 | -35.80M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | -8.788M |
| Jazz Pharmaceuticals Plc | 354.90M |
| GH Research Plc | 6.295M |
| Cosmo NV | -- |
| Viatris, Inc. | -51.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 82.60M |
| Cash from Financing (Quarterly) | -388.90M |
| Free Cash Flow | 119.30M |
| Free Cash Flow Per Share (Quarterly) | 0.4893 |
| Free Cash Flow to Equity (Quarterly) | 414.90M |
| Free Cash Flow to Firm (Quarterly) | 107.93M |
| Free Cash Flow Yield | 5.86% |